title: Mitochondrial F(0) F(1) -ATP synthase is a molecular target of 3-iodothyronamine, an endogenous metabolite of thyroid hormone.
abstract: OBJECTIVE
  3-iodothyronamine (T1AM) is a metabolite of thyroid hormone acting as a signalling molecule via non-genomic effectors and can reach intracellular targets. Because of the importance of mitochondrial F(0) F(1) -ATP synthase as a drug target, here we evaluated interactions of T1AM with this enzyme.
  
  
  METHODS
  Kinetic analyses were performed on F(0) F(1) -ATP synthase in sub-mitochondrial particles and soluble F(1) -ATPase. Activity assays and immunodetection of the inhibitor protein IF(1) were used and combined with molecular docking analyses. Effects of T1AM on H9c2 cardiomyocytes were measured by in situ respirometric analysis.
  
  
  RESULTS
  T1AM was a non-competitive inhibitor of F(0) F(1) -ATP synthase whose binding was mutually exclusive with that of the inhibitors IF(1) and aurovertin B. Both kinetic and docking analyses were consistent with two different binding sites for T1AM. At low nanomolar concentrations, T1AM bound to a high-affinity region most likely located within the IF(1) binding site, causing IF(1) release. At higher concentrations, T1AM bound to a low affinity-region probably located within the aurovertin binding cavity and inhibited enzyme activity. Low nanomolar concentrations of T1AM increased ADP-stimulated mitochondrial respiration in cardiomyocytes, indicating activation of F(0) F(1) -ATP synthase consistent with displacement of endogenous IF(1,) , reinforcing the in vitro results.
  
  
  CONCLUSIONS
  Effects of T1AM on F(0) F(1) -ATP synthase were twofold: IF(1) displacement and enzyme inhibition. By targeting F(0) F(1) -ATP synthase within mitochondria, T1AM might affect cell bioenergetics with a positive effect on mitochondrial energy production at low, endogenous, concentrations. T1AM putative binding locations overlapping with IF(1) and aurovertin binding sites are described.
authors.affiliation: Department of Medical and Biological Sciences, MATI Centre of Excellence, University of Udine, Udine, Italy.
authors.forename: S
authors.initials: S
authors.lastname: Cumero
authors.forename: F
authors.initials: F
authors.lastname: Fogolari
authors.forename: R
authors.initials: R
authors.lastname: Domenis
authors.forename: R
authors.initials: R
authors.lastname: Zucchi
authors.forename: I
authors.initials: I
authors.lastname: Mavelli
authors.forename: S
authors.initials: S
authors.lastname: Contessi
mesh_terms: D000818:Animals; D001665:Binding Sites; D015153:Blotting, Western; D002417:Cattle; D007700:Kinetics; D008929:Mitochondria, Heart / Q000201:enzymology*; D008958:Models, Molecular; D015394:Molecular Structure; D010101:Oxygen Consumption; D006180:Proton-Translocating ATPases / Q000235:genetics / Q000378:metabolism*; D000077185:Resveratrol; D015398:Signal Transduction; D013267:Stilbenes; D013970:Thyronines / Q000494:pharmacology*
chemical_list: C487948:3-iodothyronamine; D013267:Stilbenes; D013970:Thyronines; D006180:Proton-Translocating ATPases; D000077185:Resveratrol